Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)

The Oncologist
Grant A McArthurKendall Stevinson

Abstract

There are limited real-world data on health care resource utilization (HCRU) among advanced melanoma patients. The objective of this study was to describe HCRU and health care costs associated with the management of advanced melanoma patients receiving ipilimumab. This retrospective multinational, observational study included advanced melanoma patients from Australia, Germany, Italy, and Spain who had received at least 1 dose of ipilimumab. Data extracted from medical charts included inpatient admissions, outpatient visits, surgical procedures, laboratory investigations, radiation therapy, imaging studies, and concomitant medications. Cost estimates were based on unit costs from country-specific standard reimbursement sources. Subgroup analyses were performed for BRAF mutation status and ipilimumab refractory patients, who had disease progression within 24 weeks of their last dose of ipilimumab. Mean age of 362 enrolled patients was 60.6 years (standard deviation [SD] 14.4). During a median follow-up period of 30.2 weeks, 57% of patients were admitted to hospital and 16% underwent surgery. Health care resource utilization rates varied substantially across countries and were highest in Germany. Concomitant medications to treat a...Continue Reading

References

Mar 19, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Brenda MotheralPaul Stang
Sep 3, 2004·The New England Journal of Medicine·Hensin TsaoArthur J Sober
Nov 5, 2004·Australian Health Review : a Publication of the Australian Hospital Association·Jeff R J Richardson, Leonie Segal
Aug 13, 2005·Cell Cycle·Massimo LibraJames A McCubrey
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward L KornJohn M Kirkwood
May 9, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DummerUNKNOWN ESMO Guidelines Working Group
Oct 23, 2008·Journal of the American College of Cardiology·Anthony N DeMaria
Oct 31, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joel W HayLizheng Shi
Nov 6, 2009·Actas dermo-sifiliográficas·F M Almazán-FernándezJ J Moreno-Villalonga
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Apr 7, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K JohnstonM van Baardewijk
Nov 3, 2012·Journal of Experimental & Clinical Cancer Research : CR·Michele MaioCarlo Lucioni
Jul 3, 2013·The British Journal of Dermatology·V Nikolaou, A J Stratigos
Apr 2, 2014·International Journal of Evidence-based Healthcare·Jianbo ChangZheng-Gang Bai
Apr 10, 2014·Asia-Pacific Journal of Clinical Oncology·Michael P Brown, Georgina V Long
Apr 12, 2014·BMC Health Services Research·Florian KoerberWolf Rogowski
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Nov 5, 2015·Public Health Research & Practice·Amalie DydaBette Liu

❮ Previous
Next ❯

Citations

Apr 5, 2019·Journal of Managed Care & Specialty Pharmacy·Andrew J KlinkFrank Xiaoqing Liu
Jan 31, 2020·The British Journal of Dermatology·A BujaC R Rossi
Feb 23, 2019·Integrative Cancer Therapies·Michail NikolaouMaria Tolia
Oct 15, 2019·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·E K LindqvistI Schultz

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
PBAC

Software Mentioned

MELODY

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.